194 related articles for article (PubMed ID: 28317800)
21. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
Cirillo DM; Piana F; Frisicale L; Quaranta M; Riccabone A; Penati V; Vaccarino P; Marchiaro G
New Microbiol; 2004 Jul; 27(3):221-7. PubMed ID: 15460524
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
Khalil KF; Butt T
J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
[TBL] [Abstract][Full Text] [Related]
23. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.
Sharma M; Sethi S; Mishra B; Sengupta C; Sharma SK
Indian J Med Res; 2003 Feb; 117():76-80. PubMed ID: 12931842
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
Biadglegne F; Mulu A; Rodloff AC; Sack U
Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis.
Sharma SK; Kohli M; Yadav RN; Chaubey J; Bhasin D; Sreenivas V; Sharma R; Singh BK
PLoS One; 2015; 10(10):e0141011. PubMed ID: 26496123
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the analytical performance of the Xpert MTB/RIF assay.
Blakemore R; Story E; Helb D; Kop J; Banada P; Owens MR; Chakravorty S; Jones M; Alland D
J Clin Microbiol; 2010 Jul; 48(7):2495-501. PubMed ID: 20504986
[TBL] [Abstract][Full Text] [Related]
27. How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?
Timire C; Takarinda KC; Harries AD; Mutunzi H; Manyame-Murwira B; Kumar AMV; Sandy C
Trans R Soc Trop Med Hyg; 2018 Jun; 112(6):285-293. PubMed ID: 29992299
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
Ciftçi IH; Aslan MH; Aşık G
Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay.
Butt T; Ahmad RN; Afzal RK; Mahmood A; Anwar M
J Pak Med Assoc; 2004 Jul; 54(7):379-82. PubMed ID: 15449922
[TBL] [Abstract][Full Text] [Related]
30. Microscopic observation drug-susceptibility assay vs. Xpert
Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
[TBL] [Abstract][Full Text] [Related]
31. Xpert® MTB/RIF: Usefulness for the diagnosis of tuberculosis and resistance to rifampicin.
Vergara Gómez A; González-Martín J; García-Basteiro AL
Med Clin (Barc); 2017 Nov; 149(9):399-405. PubMed ID: 28739268
[TBL] [Abstract][Full Text] [Related]
32. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
33. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
35. Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting.
Brandao AP; Pinhata JMW; Simonsen V; Oliveira RS; Ghisi KT; Rabello MCS; Fukasava S; Ferrazoli L
Tuberculosis (Edinb); 2020 Dec; 125():102004. PubMed ID: 33017720
[TBL] [Abstract][Full Text] [Related]
36. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis.
Mäkinen J; Marttila HJ; Marjamäki M; Viljanen MK; Soini H
J Clin Microbiol; 2006 Feb; 44(2):350-2. PubMed ID: 16455882
[TBL] [Abstract][Full Text] [Related]
37. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
Evans D; Schnippel K; Govathson C; Sineke T; Black A; Long L; Berhanu R; Rosen S
PLoS One; 2017; 12(7):e0181238. PubMed ID: 28746344
[TBL] [Abstract][Full Text] [Related]
38. The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China.
Lu J; Li H; Dong F; Shi J; Yang H; Han S; Chu P; Zhao Y; Song W; Guo Y; Zhao S
Biomed Res Int; 2017; 2017():5857369. PubMed ID: 29359155
[TBL] [Abstract][Full Text] [Related]
39. Discordant rifampicin susceptibility results are associated with Xpert
Berhanu RH; Schnippel K; Kularatne R; Firnhaber C; Jacobson KR; Horsburgh CR; Lippincott CK
Int J Tuberc Lung Dis; 2019 Mar; 23(3):358-362. PubMed ID: 30940300
[TBL] [Abstract][Full Text] [Related]
40. MTB-DR-RIF 9G test: Detection and discrimination of tuberculosis and multi-drug resistant tuberculosis strains.
Song KS; Nimse SB; Cho NH; Sung N; Kim HJ; Yang J; Kim T
Tuberculosis (Edinb); 2015 Dec; 95(6):780-785. PubMed ID: 26381057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
